Philip Morris International 8-K

Summary

Q3 and first nine-month 2026 results, with an update to FY2026 guidance. Q3 revenue, gross profit and operating income reached quarterly records; adjusted diluted EPS rose 5.4% to a record $2.36, while reported diluted EPS fell 4.9% to $2.12, mainly due to a non-cash fair-value adjustment on equity investments. Growth reflected pricing and smoke-free volume momentum, alongside resilient combustibles; PMI reduced its forecast currency benefit to adjusted EPS to $0.18 from $0.24.

Key Figures

• Growth drivers included 7.1% organic revenue growth in Q3, led by pricing in international combustibles and the U.S.; total shipment volume rose 0.6%, including 2.7% growth in smoke-free products. A favorable restructuring of distribution terms also helped international combustibles revenue, but PMI said it is not expected to recur at the same level.
• Cash was $6.68B and total debt $47.6B at 9/30/2026, versus $4.87B and $48.8B at 12/31/2025; net debt fell to $40.9B from $44.0B, and net debt to adjusted EBITDA to 2.17x from 2.53x.
• Quarterly dividend increased 8.8% to $1.60 per share, or $6.40 annualized.

Against earlier guidance (derived from earlier filings)

Guidance

PMI said organic revenue growth is more likely in the middle or upper half of its range, while organic operating income growth is more likely in the middle or lower half, reflecting geopolitical cost pressures and increased U.S. growth investment.

Guidance changes, derived from earlier filings

Metric	Period	Earlier guidance	Guidance now	Change
Reported diluted EPS, GAAP	FY2026	$7.28-$7.43	$7.11-$7.26	lowered
Adjusted diluted EPS, non-GAAP	FY2026	$8.35-$8.50; 10.7%-12.7% growth	$8.29-$8.44; +9.9%-11.9% Y/Y	lowered
Adjusted diluted EPS excluding currency, non-GAAP	FY2026	$8.11-$8.26; 7.5%-9.5% growth	$8.11-$8.26; +7.5%-9.5% Y/Y	reaffirmed
Favorable currency impact on adjusted EPS	FY2026	$0.15	$0.18 per share	raised
Organic revenue growth	FY2026	5%-7%	5%-7%	reaffirmed
Organic operating income growth	FY2026	7%-9%	7%-9%	reaffirmed
Operating cash flow	FY2026	≈$13.5B	≈$13.5B	reaffirmed
Capital expenditures	FY2026	$1.4B-$1.6B	$1.4B-$1.6B	reaffirmed

Investor Takeaways

• Q4 ZYN investment is set to increase; watch whether U.S. growth and category share gains continue alongside the added spending.
• Full-year organic growth and the year-end net debt to adjusted EBITDA ratio will show whether performance tracks the updated forecast amid energy-related cost pressures and Ukraine-related disruptions.